Skip to content

Comparison of two regimes of Hydrocortisone for critically ill patients

Comparison of Hydrocortisone as intermittent bolus or continuous infusion in critically ill patients: A Prospective Randomized Trial - nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067142
Enrollment
88
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Hydrocortisone: 200 mg/day over 7 days period Control Intervention1: Hydrocortisone: 200 mg/day as conventional bolus therapy (50-mg IV bolus diluted in 5ml normal saline every 6 hours)

Sponsors

University College of Medical Siences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed to have sepsis requiring norepinephrine for blood pressure maintenance

Exclusion criteria

Exclusion criteria: Known case of cardiac dysfunction, diabetes, on steroid therapy prior to illness, received etomidate, on vasopressors for more than 24 h before ICU admission

Design outcomes

Primary

MeasureTime frame
Shock resolutionTimepoint: once, at 7 days after recruitment

Secondary

MeasureTime frame
Duration of vasopressor therapyTimepoint: Once;Average daily blood glucoseTimepoint: 4 hourly;Average daily insulin requirementTimepoint: 4 hourly;Recurrence of new episode of septic shock after 24-hour discontinuation of vasopressorsTimepoint: Once, after 24-hour discontinuation of vasopressors

Countries

India

Contacts

Public ContactDr Rashmi Salhotra

University College of Medical Sciences, Delhi

rashmichabra@yahoo.com9911317334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026